Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 75,000 full-time employees.  The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Pfizer Inc. adalah perusahaan biopharmaceutical global yang berbasis riset, yang terlibat dalam penemuan, pengembangan, produksi, pemasaran, penjualan, dan distribusi produk biopharmaceutical di seluruh dunia. Perusahaan ini berkantor pusat di New York City, New York, dan saat ini mempekerjakan 75.000 karyawan penuh waktu. Perusahaan ini terlibat dalam penemuan, pengembangan, produksi, pemasaran, penjualan, dan distribusi produk biopharmaceutical di seluruh dunia. Segmen Biopharma-nya mencakup Divisi Komersial Pfizer AS dan Divisi Komersial Internasional Pfizer. Kategori produknya mencakup onkologi, perawatan primer, dan perawatan spesialis. Produk onkologinya meliputi Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, dan Talzenna. Produk perawatan primernya meliputi Eliquis, Nurtec ODT/Vydura, Zavzpret, keluarga Prevnar, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, dan Paxlovid. Produk perawatan spesialisnya meliputi Xeljanz, Enbrel (di luar Amerika Serikat dan Kanada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, keluarga Vyndaqel, Genotropin, dan lainnya. PF-08653944 adalah agonis reseptor GLP-1 yang sangat lama bertindak dan sepenuhnya bias.

Pfizer

NVIDIA

Google

Apple

Microsoft

Amazon

Space Exploration Technologies Corp.

Taiwan Semiconductor

Broadcom

Tesla

Meta Platforms

Micron Technology

Berkshire Hathaway

Eli Lilly

Walmart

JPMorgan

ASML

Intel

Visa

Exxon Mobil

Johnson & Johnson

Oracle

Cisco

Lam Research

Applied Materials

Costco

MasterCard

SPDR S&P500 ETF

Caterpillar

AbbVie

Bank of America

Chevron

UnitedHealth Group

Coca-Cola

General Electric

Procter & Gamble

Netflix

Morgan Stanley

Home Depot

Goldman Sachs

Palantir

Vanguard Total Stock Market ETF

Merck

Philip Morris

Novartis

Royal Bank of Canada

AstraZeneca

Texas Instruments

Alibaba

Dell

Raytheon Technologies

Marvell Technology

Shell

Linde PLC

Citigroup

Wells Fargo

Thermo Fisher Scientific Inc

Toyota

Palo Alto Networks

QUALCOMM

American Express

Seagate Technology

Arista Networks

T-Mobile

Analog Devices

McDonald's

Invesco QQQ Trust

Verizon

PepsiCo

Toronto-Dominion Bank

TotalEnergies

Novo Nordisk

Amgen

Banco Santander

Western Digital

PDD Holdings Inc - ADR

NextEra Energy

CrowdStrike

Disney

Boeing

BlackRock

AT&T

Anheuser-Busch Inbev

Union Pacific

HSBC Holdings PLC

Charles Schwab

Southern Copper

Arm Holdings PLC - ADR

Gilead Sciences

Deere

Corning

Abbott

Blackstone

Uber

Intuitive Surgical

Pfizer Stock

About Pfizer

Key Statistics

Insights

People Also Bought